274 related articles for article (PubMed ID: 31629061)
21. Characterization of DLL3-positive circulating tumor cells (CTCs) in patients with small cell lung cancer (SCLC) and evaluation of their clinical relevance during front-line treatment.
Messaritakis I; Nikolaou M; Koinis F; Politaki E; Koutsopoulos A; Lagoudaki E; Vetsika EK; Georgoulias V; Kotsakis A
Lung Cancer; 2019 Sep; 135():33-39. PubMed ID: 31447000
[TBL] [Abstract][Full Text] [Related]
22. Liquid biopsy: current technology and clinical applications.
Nikanjam M; Kato S; Kurzrock R
J Hematol Oncol; 2022 Sep; 15(1):131. PubMed ID: 36096847
[TBL] [Abstract][Full Text] [Related]
23. AR gene rearrangement analysis in liquid biopsies reveals heterogeneity in lethal prostate cancer.
Daniel M; Knutson TP; Sperger JM; Li Y; Singh A; Stahlfeld CN; Passow C; Auch B; Lang JM; Dehm SM
Endocr Relat Cancer; 2021 Aug; 28(9):645-655. PubMed ID: 34280123
[TBL] [Abstract][Full Text] [Related]
24. Chromosomal Instability Estimation Based on Next Generation Sequencing and Single Cell Genome Wide Copy Number Variation Analysis.
Greene SB; Dago AE; Leitz LJ; Wang Y; Lee J; Werner SL; Gendreau S; Patel P; Jia S; Zhang L; Tucker EK; Malchiodi M; Graf RP; Dittamore R; Marrinucci D; Landers M
PLoS One; 2016; 11(11):e0165089. PubMed ID: 27851748
[TBL] [Abstract][Full Text] [Related]
25. Identification of Circulating Tumor DNA for the Early Detection of Small-cell Lung Cancer.
Fernandez-Cuesta L; Perdomo S; Avogbe PH; Leblay N; Delhomme TM; Gaborieau V; Abedi-Ardekani B; Chanudet E; Olivier M; Zaridze D; Mukeria A; Vilensky M; Holcatova I; Polesel J; Simonato L; Canova C; Lagiou P; Brambilla C; Brambilla E; Byrnes G; Scelo G; Le Calvez-Kelm F; Foll M; McKay JD; Brennan P
EBioMedicine; 2016 Aug; 10():117-23. PubMed ID: 27377626
[TBL] [Abstract][Full Text] [Related]
26. The application of circulating tumor cell and cell-free DNA liquid biopsies in ovarian cancer.
Balla A; Bhak J; Biró O
Mol Cell Probes; 2022 Dec; 66():101871. PubMed ID: 36283501
[TBL] [Abstract][Full Text] [Related]
27. Genomic alterations and transcriptional phenotypes in circulating tumor DNA and matched metastatic tumor.
Takahashi N; Pongor L; Agrawal SP; Shtumpf M; Rajapakse VN; Shafiei A; Schultz CW; Kim S; Roame D; Carter P; Vilimas R; Nichols S; Desai P; Figg WD; Bagheri M; Teif VB; Thomas A
bioRxiv; 2024 Jun; ():. PubMed ID: 38895436
[TBL] [Abstract][Full Text] [Related]
28. Longitudinal detection of subcategorized CD44v6
Wang Y; Zhang L; Tan J; Zhang Z; Liu Y; Hu X; Lu B; Gao Y; Tong L; Liu Z; Zhang H; Lin PP; Li B; Gires O; Zhang T
Cancer Lett; 2023 Sep; 571():216337. PubMed ID: 37553013
[TBL] [Abstract][Full Text] [Related]
29. Current Status and Future Perspectives of Liquid Biopsy in Small Cell Lung Cancer.
Mondelo-Macía P; García-González J; León-Mateos L; Castillo-García A; López-López R; Muinelo-Romay L; Díaz-Peña R
Biomedicines; 2021 Jan; 9(1):. PubMed ID: 33430290
[TBL] [Abstract][Full Text] [Related]
30. Genetic Profiling of Cell-Free DNA From Pleural Effusion in Advanced Lung Cancer as a Surrogate for Tumor Tissue and Revealed Additional Clinical Actionable Targets.
Tu HY; Li YS; Bai XY; Sun YL; Zheng MY; Ke EE; Liao RQ; Jiang BY; Lin JX; Huang J; Xu BF; Yang JJ; Zhang XC; Zhou Q; Wang BC; Chen HJ; Tong X; Yu R; Wu X; Zhu D; Wu YL
Clin Lung Cancer; 2022 Mar; 23(2):135-142. PubMed ID: 34645582
[TBL] [Abstract][Full Text] [Related]
31. The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients.
Zill OA; Banks KC; Fairclough SR; Mortimer SA; Vowles JV; Mokhtari R; Gandara DR; Mack PC; Odegaard JI; Nagy RJ; Baca AM; Eltoukhy H; Chudova DI; Lanman RB; Talasaz A
Clin Cancer Res; 2018 Aug; 24(15):3528-3538. PubMed ID: 29776953
[No Abstract] [Full Text] [Related]
32. Activation of PI3K/AKT Pathway Is a Potential Mechanism of Treatment Resistance in Small Cell Lung Cancer.
Jin Y; Chen Y; Tang H; Hu X; Hubert SM; Li Q; Su D; Xu H; Fan Y; Yu X; Chen Q; Liu J; Hong W; Xu Y; Deng H; Zhu D; Li P; Gong Y; Xia X; Gay CM; Zhang J; Chen M
Clin Cancer Res; 2022 Feb; 28(3):526-539. PubMed ID: 34921019
[TBL] [Abstract][Full Text] [Related]
33. Discordant and heterogeneous clinically relevant genomic alterations in circulating tumor cells vs plasma DNA from men with metastatic castration resistant prostate cancer.
Gupta S; Hovelson DH; Kemeny G; Halabi S; Foo WC; Anand M; Somarelli JA; Tomlins SA; Antonarakis ES; Luo J; Dittamore RV; George DJ; Rothwell C; Nanus DM; Armstrong AJ; Gregory SG
Genes Chromosomes Cancer; 2020 Apr; 59(4):225-239. PubMed ID: 31705765
[TBL] [Abstract][Full Text] [Related]
34. Using circulating cell-free DNA to monitor personalized cancer therapy.
Oellerich M; Schütz E; Beck J; Kanzow P; Plowman PN; Weiss GJ; Walson PD
Crit Rev Clin Lab Sci; 2017 May; 54(3):205-218. PubMed ID: 28393575
[TBL] [Abstract][Full Text] [Related]
35. The feasibility of using liquid biopsies as a complementary assay for copy number aberration profiling in routinely collected paediatric cancer patient samples.
Van Paemel R; Vandeputte C; Raman L; Van Thorre J; Willems L; Van Dorpe J; Van Der Linden M; De Wilde J; De Koker A; Menten B; Devalck C; Vicha A; Grega M; Schleiermacher G; Iddir Y; Chicard M; van Zogchel L; Stutterheim J; Lak NSM; Tytgat GAM; Laureys G; Speleman F; De Wilde B; Lammens T; De Preter K; Van Roy N
Eur J Cancer; 2022 Jan; 160():12-23. PubMed ID: 34794856
[TBL] [Abstract][Full Text] [Related]
36. Molecular phenotyping of small cell lung cancer using targeted cfDNA profiling of transcriptional regulatory regions.
Hiatt JB; Doebley AL; Arnold HU; Adil M; Sandborg H; Persse TW; Ko M; Wu F; Quintanal Villalonga A; Santana-Davila R; Eaton K; Dive C; Rudin CM; Thomas A; Houghton AM; Ha G; MacPherson D
Sci Adv; 2024 Apr; 10(15):eadk2082. PubMed ID: 38598634
[TBL] [Abstract][Full Text] [Related]
37. Circulating tumor cells (CTCs)/circulating tumor endothelial cells (CTECs) and their subtypes in small cell lung cancer: Predictors for response and prognosis.
Zhu HH; Liu YT; Feng Y; Zhang LN; Zhang TM; Dong GL; Xing PY; Wang HY; Shi YK; Hu XS
Thorac Cancer; 2021 Oct; 12(20):2749-2757. PubMed ID: 34423906
[TBL] [Abstract][Full Text] [Related]
38. Longitudinal monitoring of cell-free DNA methylation in ALK-positive non-small cell lung cancer patients.
Janke F; Angeles AK; Riediger AL; Bauer S; Reck M; Stenzinger A; Schneider MA; Muley T; Thomas M; Christopoulos P; Sültmann H
Clin Epigenetics; 2022 Dec; 14(1):163. PubMed ID: 36461127
[TBL] [Abstract][Full Text] [Related]
39. Will liquid biopsies improve outcomes for patients with small-cell lung cancer?
Blackhall F; Frese KK; Simpson K; Kilgour E; Brady G; Dive C
Lancet Oncol; 2018 Sep; 19(9):e470-e481. PubMed ID: 30191851
[TBL] [Abstract][Full Text] [Related]
40. Concordance between genomic alterations assessed by next-generation sequencing in tumor tissue or circulating cell-free DNA.
Chae YK; Davis AA; Carneiro BA; Chandra S; Mohindra N; Kalyan A; Kaplan J; Matsangou M; Pai S; Costa R; Jovanovic B; Cristofanilli M; Platanias LC; Giles FJ
Oncotarget; 2016 Oct; 7(40):65364-65373. PubMed ID: 27588476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
